$17.050
-0.198 (-1.16%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CTNM por análisis de gráficos similares
Alphio's CTNM stock price prediction model matches the current Contineum Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.26 (+1.26%). The 1-week path is $17.48 (+2.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Contineum Therapeutics Inc?
Contineum Therapeutics Inc is a good buy right now due to its current price of $17.05, which is below the analyst price target of $24, indicating significant upside potential. Additionally, the company has a strong liquidity position with $236.6 million in cash, which allows it to fund operations through mid-2029 despite ongoing losses. The RSI is at 66.187, suggesting that the stock is in a strong momentum phase, and the recent positive trial results for PIPE-791 may drive future growth. However, the main risk is the negative earnings trend, with a projected EPS of -0.40 for Q2 2026, which could affect investor sentiment.
CTNM cerró en $17.05 el Friday, tras bajar -1.16%
Contineum Therapeutics Inc (CTNM) last closed at $17.05, losing -1.16%. These facts feed the 1-day and 1-week CTNM price prediction above.
Factores de la previsión
Los factores de la previsión de Contineum Therapeutics Inc (CTNM) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CTNM, ordenadas por similitud.
Análisis de estacionalidad de CTNM
Historically the probability of a positive August return for CTNM is 66.67%. July offers the highest probability of a positive month at 66.67%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CTNM
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $3.87 | $4.25 | $4.61 | -75.05% |
| Sep 2026 | $4.42 | $4.44 | $4.81 | -73.98% |
| Oct 2026 | $3.06 | $3.88 | $4.41 | -77.23% |
| Nov 2026 | $3.08 | $3.92 | $3.98 | -77.03% |
| Dec 2026 | $3.75 | $4.57 | $4.88 | -73.21% |
En 2026, se proyecta que Contineum Therapeutics Inc (CTNM) oscile entre $3.06 y $4.88.
Previsión mensual de Contineum Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Contineum Therapeutics Inc promedie $4.25, con un mínimo de $3.87 y un máximo de $4.61.
En Sep de 2026, se proyecta que Contineum Therapeutics Inc promedie $4.44, con un mínimo de $4.42 y un máximo de $4.81.
En Oct de 2026, se proyecta que Contineum Therapeutics Inc promedie $3.88, con un mínimo de $3.06 y un máximo de $4.41.
En Nov de 2026, se proyecta que Contineum Therapeutics Inc promedie $3.92, con un mínimo de $3.08 y un máximo de $3.98.
En Dec de 2026, se proyecta que Contineum Therapeutics Inc promedie $4.57, con un mínimo de $3.75 y un máximo de $4.88.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.